Aspirin, nonsteroidal anti-inflammatory drugs, paracetamol and risk of endometrial cancer: A case-control study, systematic review and meta-analysis

International Journal of Cancer

Volumn 132, Issue 5, 2013, Pages 1146-1155

  Neill, Annette S ^a,b   Nagle, Christina M ^a   Protani, Melinda M ^a   Obermair, Andreas ^c   Spurdle, Amanda B ^a   Webb, Penelope M ^a  

^a QIMR BERGHOFER MEDICAL RESEARCH INSTITUTE   (Australia)

^b UNIVERSITY OF QUEENSLAND   (Australia)

^c ROYAL BRISBANE AND WOMEN'S HOSPITAL   (Australia)

Author keywords

aspirin (acetylsalicylic acid); endometrial cancer; meta analysis; nonsteroidal anti inflammatory drugs; paracetamol (acetaminophen)

Indexed keywords

ACETYLSALICYLIC ACID; NONSTEROID ANTIINFLAMMATORY AGENT; PARACETAMOL;

ANGIOGENESIS; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER PREVENTION; CANCER RISK; CASE CONTROL STUDY; DISEASE ASSOCIATION; DOSE RESPONSE; ENDOMETRIUM CANCER; HUMAN; LOW DRUG DOSE; META ANALYSIS; OBESITY; POPULATION RESEARCH; PRIORITY JOURNAL; RANDOM EFFECT MODEL; RANDOMIZED CONTROLLED TRIAL (TOPIC); STATISTICAL ANALYSIS; SYSTEMATIC REVIEW;

ACETAMINOPHEN; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ASPIRIN; AUSTRALIA; CASE-CONTROL STUDIES; CONFIDENCE INTERVALS; ENDOMETRIAL NEOPLASMS; FEMALE; HUMANS; LOGISTIC MODELS; MIDDLE AGED; OBESITY; ODDS RATIO; RISK;

EID: 84872854865     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.27717     Document Type: Article

References (43)

1. Ferlay J, Shin HR, Bray F, et al. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer 2010; 127: 2893-917.
2. Dossus L, Allen N, Kaaks R, et al. Reproductive risk factors and endometrial cancer: the European Prospective Investigation into Cancer and Nutrition. Int J Cancer 2009; 127: 442-51.
3. Purdie DM, Green AC,. Epidemiology of endometrial cancer. Best Pract Res Clin Obstet Gynaecol 2001; 15: 341-54.
4. Modugno F, Ness RB, Chen C, et al. Inflammation and endometrial cancer: a hypothesis. Cancer Epidemiol Biomarkers Prev 2005; 14: 2840-7.
5. Wallace AE, Gibson DA, Saunders PT, et al. Inflammatory events in endometrial adenocarcinoma. J Endocrinol 2010; 206: 141-57.
6. O'Byrne KJ, Dalgleish AG,. Chronic immune activation and inflammation as the cause of malignancy. Br J Cancer 2001; 85: 473-83.
7. Dubois RN, Abramson SB, Crofford L, et al. Cyclooxygenase in biology and disease. FASEB J 1998; 12: 1063-73.
8. Ghosh N, Chaki R, Mandal V, et al. COX-2 as a target for cancer chemotherapy. Pharmacol Rep 2010; 62: 233-44.
9. Langley RE, Burdett S, Tierney JF, et al. Aspirin and cancer: has aspirin been overlooked as an adjuvant therapy? Br J Cancer 2011; 105: 1107-13.
10. Cuzick J, Otto F, Baron JA, et al. Aspirin and non-steroidal anti-inflammatory drugs for cancer prevention: an international consensus statement. The lancet oncology 2009; 10: 501-7.
11. Bosetti C, Bravi F, Talamini R, et al. Aspirin and risk of endometrial cancer: a case-control study from Italy. Eur J Cancer Prev 2010; 19: 401-3.
12. Danforth KN, Gierach GL, Brinton LA, et al. Nonsteroidal anti-inflammatory drug use and endometrial cancer risk in the NIH-AARP Diet and Health Study. Cancer Prev Res (Phila) 2009; 2: 466-72.
13. Fortuny J, Sima C, Bayuga S, et al. Risk of endometrial cancer in relation to medical conditions and medication use. Cancer Epidemiol Biomarkers Prev 2009; 18: 1448-56.
14. Moysich KB, Baker JA, Rodabaugh KJ, et al. Regular analgesic use and risk of endometrial cancer. Cancer Epidemiol Biomarkers Prev 2005; 14: 2923-8.
15. Prizment AE, Folsom AR, Anderson KE,. Nonsteroidal anti-inflammatory drugs and risk for ovarian and endometrial cancers in the Iowa Women's Health Study. Cancer Epidemiol Biomarkers Prev 2010; 19: 435-42.
16. Schreinemachers DM, Everson RB,. Aspirin use and lung, colon, and breast cancer incidence in a prospective study. Epidemiology 1994; 5: 138-46.
17. Bodelon C, Doherty JA, Chen C, et al. Use of nonsteroidal antiinflammatory drugs and risk of endometrial cancer. Am J Epidemiol 2009; 170: 1512-7.
18. Viswanathan AN, Feskanich D, Schernhammer ES, et al. Aspirin, NSAID, and acetaminophen use and the risk of endometrial cancer. Cancer Res 2008; 68: 2507-13.
19. Botting RM,. Mechanism of action of acetaminophen: is there a cyclooxygenase 3? Clin Infect Dis 2000; 31 (Suppl 5): S202-10.
20. Silverberg S, Kurman, RJ, Nogales F, et al. Tumours of the uterine corpus. In:, Tavassoli F, Devilee P, eds. World Health Organization Classification of Tumours. Pathology and genetics of tumours of the breast and female genital organs. Lyon: IRAC Press, 2003.
21. Cleophas TJ, Zwinderman AH,. Random effects models in clinical research. Int J Clin Pharmacol Ther 2008; 46: 421-7.
22. UBM Medica Australia. MIMS Abbreviated Prescribing Information. St Leonards, NSW: MIMS Australia, 1996-2010.
23. Cook NR, Lee IM, Gaziano JM, et al. Low-dose aspirin in the primary prevention of cancer: the Women's Health Study: a randomized controlled trial. JAMA 2005; 294: 47-55.
24. Rothwell PM, Wilson M, Elwin CE, et al. Long-term effect of aspirin on colorectal cancer incidence and mortality: 20-year follow-up of five randomised trials. Lancet 2010; 376: 1741-50.
25. Harvey AE, Lashinger LM, Hursting SD,. The growing challenge of obesity and cancer: an inflammatory issue. Ann N Y Acad Sci 2011; 1229: 45-52.
26. Simmons DL, Botting RM, Hla T,. Cyclooxygenase isozymes: the biology of prostaglandin synthesis and inhibition. Pharmacol Rev 2004; 56: 387-437.
27. Arango HA, Icely S, Roberts WS, et al. Aspirin effects on endometrial cancer cell growth. Obstet Gynecol 2001; 97: 423-7.
28. Gao J, Niwa K, Sun W, et al. Non-steroidal anti-inflammatory drugs inhibit cellular proliferation and upregulate cyclooxygenase-2 protein expression in endometrial cancer cells. Cancer Sci 2004; 95: 901-7.
29. Bardia A, Olson JE, Vachon CM, et al. Effect of aspirin and other NSAIDs on postmenopausal breast cancer incidence by hormone receptor status: results from a prospective cohort study. Breast Cancer Res Treat 2011; 126: 149-55.
30. Gierach GL, Lacey JV, Jr, Schatzkin A, et al. Nonsteroidal anti-inflammatory drugs and breast cancer risk in the National Institutes of Health-AARP Diet and Health Study. Breast Cancer Res 2008; 10: R38.
31. Mahmud SM, Franco EL, Aprikian AG,. Use of nonsteroidal anti-inflammatory drugs and prostate cancer risk: a meta-analysis. Int J Cancer 2010; 127: 1680-91.
32. Jacobs EJ, Rodriguez C, Mondul AM, et al. A large cohort study of aspirin and other nonsteroidal anti-inflammatory drugs and prostate cancer incidence. J Natl Cancer Inst 2005; 97: 975-80.
33. Akhmedkhanov A, Toniolo P, Zeleniuch-Jacquotte A, et al. Aspirin and lung cancer in women. Br J Cancer 2002; 87: 49-53.
34. Oh SW, Myung SK, Park JY, et al. Aspirin use and risk for lung cancer: a meta-analysis. Ann Oncol 2011; 22: 2456-65.
35. Abnet CC, Freedman ND, Kamangar F, et al. Non-steroidal anti-inflammatory drugs and risk of gastric and oesophageal adenocarcinomas: results from a cohort study and a meta-analysis. Br J Cancer 2009; 100: 551-7.
36. Tian W, Zhao Y, Liu S, et al. Meta-analysis on the relationship between nonsteroidal anti-inflammatory drug use and gastric cancer. Eur J Cancer Prev 2010; 19: 288-98.
37. Corley DA, Kerlikowske K, Verma R, et al. Protective association of aspirin/NSAIDs and esophageal cancer: a systematic review and meta-analysis. Gastroenterology 2003; 124: 47-56.
38. Sadeghi S, Bain CJ, Pandeya N, et al. Aspirin, nonsteroidal anti-inflammatory drugs, and the risks of cancers of the esophagus. Cancer Epidemiol Biomarkers Prev 2008; 17: 1169-78.
39. Tan XL, Reid-Lombardo KM, Bamlet WR, et al. Aspirin, nonsteroidal anti-inflammatory drugs (NSAID), acetaminophen, and pancreatic cancer risk: a clinic-based case-control study. Cancer Prev Res (Phila) 2011; 4: 1835-41.
40. Curiel-Lewandrowski C, Nijsten T, Gomez ML, et al. Long-term use of nonsteroidal anti-inflammatory drugs decreases the risk of cutaneous melanoma: results of a United States case-control study. J Invest Dermatol 2011; 131: 1460-8.
41. Cheema AA,. Should people on aspirin avoid Ibuprofen? A review of the literature. Cardiol Rev 2004; 12: 174-6.
42. Jankowski JA, Limburg PJ,. Aspirin therapy for cancer: it is never too late. Br J Cancer 2011; 105: 1105-6.
43. Rostom A, Dube C, Lewin G,. Use of aspirin and NSAIDs to prevent colorectal cancer: an evidence synthesis prepared for the agency for healthcare research and quality by the University of Ottawa evidence-based practice center at the University of Ottawa, Ottawa Canada, under Contract No. 290-02-0021. AHRQ Publication No. 07-0596-EF-1. Rockville, Maryland: Agency for Healthcare Research and Quality, 2007.